A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Mass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high-risk patients who did not have known ...

Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury.

Multiple Americans have been cured of their diabetes after a groundbreaking trial that has let them put down their insulin ...

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...

Results presented here showed platelet-rich plasma injection within 6 months of total shoulder arthroplasty may lead to an ...

The Latitude trial found monthly injections nearly halve treatment failure compared to daily pills, addressing stigma and ...

Ophthalmology pioneered the clinical use of artificial intelligence (AI). Beyond automating routine tasks, including retinal ...